Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	506.85	1,063	703.02	534.19	616
Short-Term Investments	115.22	578.36	576.62	505.81	461.75
Trading Asset Securities	1,295	-	-	-	-
Cash & Short-Term Investments	1,917	1,641	1,280	1,040	1,078
Cash Growth	16.85%	28.23%	23.04%	-3.50%	51.56%
Accounts Receivable	565.57	584.25	581.82	534.93	377.13
Other Receivables	11.9	2.17	3.37	11.31	33.8
Receivables	577.47	586.42	585.18	546.25	410.92
Inventory	289.73	294.52	227.62	115.65	62.62
Other Current Assets	57.19	58.03	66.54	77.21	90.78
Total Current Assets	2,842	2,580	2,159	1,779	1,642
Property, Plant & Equipment	2,673	2,323	2,206	1,724	1,413
Long-Term Investments	111.07	-	-	-	-
Other Intangible Assets	22.79	22.98	25.91	26.57	26.52
Long-Term Deferred Tax Assets	72.26	67.25	55.91	48.31	34.47
Other Long-Term Assets	41.34	137.06	59.25	171.76	53.11
Total Assets	5,763	5,131	4,506	3,750	3,169
Accounts Payable	268.07	312.31	254.55	210.5	122.93
Accrued Expenses	226.34	226.54	210.26	170.08	128.1
Short-Term Debt	92.01	8.67	-	-	176.9
Current Portion of Long-Term Debt	-	1.3	9.17	9.03	-
Current Portion of Leases	178.4	155.27	141.45	130.72	108
Current Income Taxes Payable	154.45	162.57	134.37	85.7	77.44
Current Unearned Revenue	25.12	24.19	23.32	16.24	14.22
Other Current Liabilities	146.34	132.25	137.25	109.39	125.83
Total Current Liabilities	1,091	1,023	910.38	731.66	753.41
Long-Term Debt	-	-	1.32	10.33	-
Long-Term Leases	783.83	613.02	631.7	617.45	329.24
Long-Term Deferred Tax Liabilities	60.93	58.39	44.26	24.94	-
Other Long-Term Liabilities	71.49	93.12	88.8	36.78	47.04
Total Liabilities	2,007	1,788	1,676	1,421	1,130
Common Stock	847.25	847.25	799.29	761.23	761.23
Additional Paid-In Capital	381.92	381.92	381.92	381.92	381.92
Retained Earnings	2,388	1,960	1,488	1,056	779.86
Comprehensive Income & Other	4.51	-11.38	-5.04	-10.37	-9.12
Total Common Equity	3,622	3,178	2,664	2,188	1,914
Minority Interest	133.72	165.33	165.02	140.13	125.55
Shareholders' Equity	3,756	3,343	2,829	2,328	2,039
Total Liabilities & Equity	5,763	5,131	4,506	3,750	3,169
Total Debt	1,054	778.26	783.65	767.53	614.14
Net Cash (Debt)	863.2	862.65	495.99	272.47	463.61
Net Cash Growth	0.07%	73.92%	82.03%	-41.23%	261.16%
Net Cash Per Share	10.16	10.16	5.85	3.21	5.46
Filing Date Shares Outstanding	84.73	84.73	84.72	84.72	84.72
Total Common Shares Outstanding	84.73	84.73	84.72	84.72	84.72
Working Capital	1,751	1,557	1,249	1,047	888.66
Book Value Per Share	42.75	37.51	31.45	25.83	22.59
Tangible Book Value	3,599	3,155	2,638	2,162	1,887
Tangible Book Value Per Share	42.48	37.23	31.14	25.52	22.28
Land	179.87	179.87	179.87	179.87	179.87
Buildings	67.11	67.11	66.76	66.76	66.65
Machinery	2,442	2,165	1,884	1,480	1,346
Construction In Progress	96.01	32.82	91.84	-	-
Leasehold Improvements	643.69	615.67	473.07	340.85	306.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.